Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
9,760,822
-
Share change
-
-223,132
-
Total reported value
-
$52,514,000
-
Price per share
-
$5.38
-
Number of holders
-
30
-
Value change
-
-$2,839,280
-
Number of buys
-
12
-
Number of sells
-
19
Institutional Holders of MARINUS PHARMACEUTICALS INC - COM (MRNS) as of Q1 2016
As of 31 Mar 2016,
MARINUS PHARMACEUTICALS INC - COM (MRNS) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,760,822 shares.
The largest 10 holders included
Canaan Partners VII LLC, FRANKLIN RESOURCES INC, ORBIMED ADVISORS LLC, Arrowpoint Asset Management, LLC, New Leaf Venture Partners, L.L.C., SPHERA FUNDS MANAGEMENT LTD., DAFNA Capital Management LLC, EverPoint Asset Management, LLC, PUTNAM INVESTMENTS LLC, and VANGUARD GROUP INC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.